Prevalence of Human Papillomavirus Infection and Cervical Cancer Screening among Riverside Women of the Brazilian Amazon

Abstract

Purpose The aim of this study was to evaluate the overall and type-specific prevalence of human papillomavirus (HPV) infection among females living in riverside communities in the state of Pará, in the Eastern Brazilian Amazon. These communities are inhabited by low-income people, and are accessible only by small boats. Cervical cytology and risk factors for HPV infection were also assessed.

Methods Cervical samples from 353 women of selected communities were collected both for Papanicolau (Pap) test and HPV detection. Conventional polymerase chain reaction (PCR) and real-time PCR were used to assess the overall and type-specific prevalence of HPV-16 and HPV-18, the main oncogenic types worldwide. Epidemiological questionnaires were used for the assessment of the risk factors for HPV infection.

Results The mean age of the participants was 37 years (standard deviation [SD] ± 13.7). Most were married or with a fixed sexual partner (79%), and had a low educational level (80%) and family monthly income (< U$ 250; 53%). Overall, HPV prevalence was 16.4% (n = 58), with 8 cases of HPV-16 (2.3%) and 5 of HPV-18 (1.4%). Almost 70% of the women surveyed had never undergone the Pap test. Abnormal cytology results were found in 27.5% (n = 97) of the samples, with higher rates of HPV infection according to the severity of the lesions (p = 0.026).

Conclusions The infections by HPV-16 and HPV-18 were not predominant in our study, despite the high prevalence of overall HPV infection. Nevertheless, the oncogenic potential of these types and the low coverage of the Pap test among women from riverside communities demonstrate a potential risk for the development of cervical lesions and their progression to cervical cancer, since the access to these communities is difficult and, in most cases, these women do not have access to primary care and public health services.

Resumo

Objetivo O objetivo deste estudo foi avaliar a prevalência global e tipo-específica da infecção pelo papilomavírus humano (HPV) entre mulheres que vivem em comunidades ribeirinhas do estado do Pará, Amazônia oriental, Brasil. Estas comunidades são habitadas por pessoas de baixa renda, e são acessíveis somente por meio de pequenos barcos. A citologia cervical e os fatores de risco para a infecção por HPV também foram avaliados.

Métodos Amostras cervicais de 353 mulheres de comunidades selecionadas foram coletadas para a análise citológica e para a detecção do HPV. A prevalência global e tipo-específica dos HPV-16 e HPV-18, principais tipos oncogênicos no mundo, foram avaliadas por meio de reação em cadeia de polimerase (PCR) convencional e PCR em tempo real. Os fatores de risco para a infecção por HPV foram avaliados a partir de questionários epidemiológicos.

Resultados A idade média das participantes foi de 37 anos (desvio padrão [DP] ± 13,7). A maioria era casada ou tinha um parceiro sexual fixo (79%) e baixo nível de escolaridade (80%) e de renda familiar mensal (< U$ 250; 53%). A prevalência global do HPV foi de 16,4% (n = 58), com 8 casos de HPV-16 (2,3%) e 5 casos de HPV-18 (1,4%). Aproximadamente 70% das mulheres entrevistadas nunca tinha realizado o exame preventivo de Papanicolau. Os resultados citológicos anormais foram encontrados em 27,5% (n = 97) das amostras, com taxas mais altas da infecção por HPV de acordo com a severidade das lesões (p = 0,026).

Conclusões As infecções por HPV-16 e HPV-18 não foram predominantes em nosso estudo, apesar da alta prevalência global da infecção por HPV. No entanto, o potencial oncogênico desses tipos e a baixa cobertura do exame de Papanicolau entre mulheres de comunidades ribeirinhas demonstram um risco potencial para o desenvolvimento de lesões cervicais e sua progressão para o câncer de colo do útero, uma vez que o acesso a essas comunidades é difícil e, na maioria dos casos, estas mulheres não têm acesso aos serviços de atenção primária e de saúde pública.

Keywords

human papillomavirus 16 - human papillomavirus 18 - epidemiology - cervical cancer screening - sexually transmitted diseases

Palavras-chave

papilomavírus humano 16 - papilomavírus humano 18 - epidemiologia - rastreamento de câncer do colo do útero - doenças sexualmente transmissíveis

Authors' Contributions

DD performed the molecular identification of general and specific HPV, being primarily responsible for the analysis, interpretation of data, literature review and production of the manuscript. RV contributed to the draft of the manuscript, data interpretation, and the revision of the final version of the manuscript, providing suggestions. EB performed the cytological analysis of the samples and participated in the collection of the questionnaires. MP coordinated the collection of the samples and the application of the questionnaires. JM performed the molecular analysis of general and specific HPV, and helped in the interpretation of the data. MV was responsible for the statistical analysis of the research, and for the preparation of figures and tables. EI contributed to the analyses, data interpretation and critical review of the manuscript. HF contributed to the analyses, data interpretation and detection of HPV-16 and -18. MS was responsible for the study design, interpretation of data, and critical revision of the intellectual content of the manuscript. All authors read and approved the final draft of the manuscript.

• References

• 1 Ferenczy A, Franco E. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 2002; 3 (01) 11-16
• 2 de Sanjosé S, Diaz M, Castellsagué X. , et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7 (07) 453-459
• 3 Winer RL, Hughes JP, Feng Q. , et al. Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women. Cancer Epidemiol Biomarkers Prev 2011; 20 (04) 699-707
• 4 Moore MA, Tajima K. Cervical cancer in the asian pacific-epidemiology, screening and treatment. Asian Pac J Cancer Prev 2004; 5 (04) 349-361
• 5 Brasil. Ministério da Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2016: incidência do câncer no Brasil. Rio de Janeiro: INCA; 2016
• 6 Pinto DdaS, Fuzii HT, Quaresma JAS. Prevalence of genital HPV infection in urban and rural women in the Eastern Brazilian Amazon. Cad Saude Publica 2011; 27 (04) 769-778
• 7 Vieira RC, Monteiro JdoS, Manso EP. , et al. Prevalence of type-specific HPV among female university students from northern Brazil. Infect Agent Cancer 2015; 10: 21
• 8 Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Instituto Nacional de Câncer. Nomenclatura brasileira para laudos cervicais e condutas preconizadas. 3a ed. Rio de Janeiro: INCA; 2012
• 9 Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989; 7: 209-214
• 10 Gage JC, Partridge EE, Rausa A. , et al. Comparative performance of human papillomavirus DNA testing using novel sample collection methods. J Clin Microbiol 2011; 49 (12) 4185-4189
• 11 Ayres M, Ayres Júnior M, Ayres DL, dos Santos ASS. BioEstat 5.3 [Internet]. Tefé: Instituto de Desenvolvimento Sustentável Mamirauá; 2011 [cited 2016 Mar 22]. Available at: http://www.mamiraua.org.br/pt-br/downloads/programas/bioestat-versao-53/
• 12 Muñoz N, Bosch FX, Castellsagué X. , et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111 (02) 278-285
• 13 Duarte DV, Brito EB, Canto ASS. , et al. Frequência e genotipagem do Papilomavírus humano em mulheres de comunidades ribeirinhas do Município de Abaetetuba, Pará, Brasil. Rev Pan-Amaz Saúde 2010; 1 (03) 75-82
• 14 Brito EB, Silva ID, Stávale JN, Taromaru E, Menezess RC, Martins SJ. Amerindian women of the Brazilian Amazon and STD. Eur J Gynaecol Oncol 2006; 27 (03) 279-281
• 15 Fonseca AJ, Taeko D, Chaves TA. , et al. HPV infection and cervical screening in socially isolated indigenous women inhabitants of the Amazonian rainforest. PLoS One 2015; 10 (07) e0133635
• 16 Mendoza L, Mongelos P, Paez M. , et al. Human papillomavirus and other genital infections in indigenous women from Paraguay: a cross-sectional analytical study. BMC Infect Dis 2013; 13: 531
• 17 de Sanjose S, Almirall R, Lloveras B. , et al. Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 2003; 30 (10) 788-793
• 18 Dursun P, Senger SS, Arslan H, Kuşçu E, Ayhan A. Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis 2009; 9: 191
• 19 Lazcano-Ponce E, Herrero R, Muñoz N. , et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001; 91 (03) 412-420
• 20 Molano M, Posso H, Weiderpass E. , et al; HPV Study Group HPV Study. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002; 87 (03) 324-333
• 21 Foliaki S, Brewer N, Pearce N. , et al. Prevalence of HPV infection and other risk factors in a Fijian population. Infect Agent Cancer 2014; 9: 14
• 22 Dunne EF, Unger ER, Sternberg M. , et al. Prevalence of HPV infection among females in the United States. JAMA 2007; 297 (08) 813-819
• 23 Shew ML, Fortenberry JD, Tu W. , et al. Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women. Arch Pediatr Adolesc Med 2006; 160 (02) 151-156
• 24 Huh WK, Ault KA, Chelmow D. , et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstet Gynecol 2015; 125 (02) 330-337